$TNXP 5 SEC Filings

Filed On	Filing
17 Feb 2026	Form 5: Saenger Bradley, Chief Financial Officer Received 701 shares as a grant or award ($9.41K)
11 Feb 2022	Form 5: Saenger Bradley, Chief Financial Officer Received 18,248 shares as a grant or award ($10.6K)
11 Feb 2022	Form 5: Sullivan Gregory M, Chief Medical Officer Received 36,496 shares as a grant or award ($21.2K)
12 Feb 2021	Form 5: Saenger Bradley, Chief Financial Officer Received 493 shares as a grant or award ($503)
14 Feb 2020	Form 5: Sullivan Gregory M, Chief Medical Officer Received 59 shares as a grant or award ($1.05K) · Received 1,142 shares as a grant or award ($13.5K)
14 Feb 2020	Form 5: Saenger Bradley, Chief Financial Officer Received 59 shares as a grant or award ($1.05K) · Received 815 shares as a grant or award ($9.63K)
13 Feb 2017	Form 5: Sullivan Gregory M, Chief Medical Officer Acquired 3,296 shares (Other Transaction) ($5.74K)
13 Feb 2017	Form 5: Saenger Bradley, Chief Financial Officer Acquired 3,296 shares (Other Transaction) ($5.74K)
13 Feb 2017	Form 5: Lederman Seth, Director Acquired 3,296 shares (Other Transaction) ($5.74K)
10 Feb 2016	Form 5: Sullivan Gregory M, Chief Medical Officer Acquired 3,532 shares (Other Transaction) ($17.6K) · Acquired 2,728 shares (Other Transaction) ($17.6K)
10 Feb 2016	Form 5: Morris Jessica Edgar, Acting Chief Financial Officer Acquired 909 shares (Other Transaction) ($5.87K)
10 Feb 2016	Form 5: Lederman Seth, Director Acquired 1,741 shares (Other Transaction) ($11.2K)
10 Feb 2016	Form 5: Daugherty Bruce, See Remarks Acquired 3,532 shares (Other Transaction) ($17.6K) · Acquired 2,728 shares (Other Transaction) ($17.6K)

Comments